Nanotechnology and Drug Delivery, Volume Two: Nano-Engineering Strategies and Nanomedicines against Severe Diseases

Jose L. Arias

February 25, 2016 by CRC Press
Reference - 487 Pages - 12 Color & 57 B/W Illustrations
ISBN 9781482262711 - CAT# K24339

was $189.95

USD$151.96

SAVE ~$37.99

Add to Wish List
SAVE 25%
When you buy 2 or more print books!
See final price in shopping cart.
FREE Standard Shipping!

Features

  • Analyzes the key links to be established between nanomedicine formulation and the factors related to the routing of drug administration, further discussing advanced engineering approaches for the selective delivery and release of active agents
  • Looks at use of nanomedicines for a wide variety of ailments ranging from dental to cardiac to cancer
  • Provides a cutting-edge reference on the revolutionary conceptualization of theranosis

Summary

The recent introduction of nanomedicines in the drug therapy arena is revolutionizing the management of severe diseases. The key advance in the field is the optimization of the biological fate of drug molecules, thus improving the therapeutic effect while keeping to a very minimum the associated toxicity. Volume one of this book series, Nanoplatforms in Drug Delivery, established the basic aspects in the development of drug-loaded nanoplatforms, the so-called nanomedicines or nanodrugs, focusing on representative materials and strategies used in their formulation.

Taking advantage of the advanced conceptualizations on nanomedicine engineering that were described in volume one, volume two, Nano-Engineering Strategies and Nanomedicines against Severe Diseases, analyzes in depth special features related to the formulation of nanoplatforms for oral, dental, topical and transdermal, pulmonary and nasal, ocular and otic, vaginal, and brain drug delivery and targeting. Particular aspects of nanomedicine engineering and in vivo fate associated with the routing of drug administration are given special attention. In addition, an up-to-date view is presented on the use of nanomedicines against severe diseases, such as cancer, cardiovascular diseases, neurodegenerative disorders, infectious diseases, chronic inflammatory diseases, and metabolic diseases. The chapters analyze the key factors that need to be controlled to achieve the optimum therapeutic effect. Attention is further given to gene delivery and the recent concept of nanotheranosis.